Evidence map›Paper›PMID 34062056›Full record

ArticleBiomolecular concepts2021

Everolimus-induced effector mechanism in macrophages and survivability of Erdman, CDC1551 and HN878 strains of

Ruoqiong Cao, Kimberly To, Nala Kachour, Abrianna Beever, James Owens, Airani Sathananthan, Pooja Singh, Afsal Kolloli, Selvakumar Subbian, Vishwanath Venketaraman

Abstract read
In one paragraph

Article in Biomolecular concepts, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Exploring and exploiting the host cell autophagy during Mycobacterium tuberculosis infection.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2023
    Review
  8. Different modalities of host cell death and their impact onAmerican journal of physiology. Cell physiology · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Ruoqiong CaoCollege of Osteopathic Medicine of the Pacific, Western University of Health Sciences, Pomona, CA, USA.
Kimberly ToCollege of Osteopathic Medicine of the Pacific, Western University of Health Sciences, Pomona, CA, USA.
Nala KachourGraduate College of Biomedical Sciences, Western University of Health Sciences, Pomona, CA, USA.
Abrianna BeeverGraduate College of Biomedical Sciences, Western University of Health Sciences, Pomona, CA, USA.
James OwensCollege of Osteopathic Medicine of the Pacific, Western University of Health Sciences, Pomona, CA, USA.
Airani SathananthanCollege of Osteopathic Medicine of the Pacific, Western University of Health Sciences, Pomona, CA, USA.
Pooja SinghDepartment of Pulmonary, Allergy, and Critical Care Medicine, The University of Alabama at Birmingham, Birmingham, AL35294, USA.
Afsal KolloliThe Public Health Research Institute at New Jersey Medical School, Rutgers University, Newark, NJ 07103, USA.
Selvakumar SubbianThe Public Health Research Institute at New Jersey Medical School, Rutgers University, Newark, NJ 07103, USA.
Vishwanath VenketaramanCollege of Osteopathic Medicine of the Pacific, Western University of Health Sciences, Pomona, CA, USA; Graduate College of Biomedical Sciences, Western University of Health Sciences, Pomona, CA, USA.

Funding

Glutathione depletion in the CNS and its effects on Mtb infectionR15HL143545 · NHLBI · WESTERN UNIVERSITY OF HEALTH SCIENCES · PI VENKETARAMAN, VISHWANATH · 2019 to 2024
$852k
NHLBI NIH HHS R15 HL143545
6 · The paper itself

Abstract

With a disease as widespread and destructive as tuberculosis, more effective drugs and healthcare strategies, in addition to the current antibiotics regimen, are crucial for the enhanced well-being of millions of people suffering from the disease. Host-directed therapy is a new and emerging concept in treating chronic infectious diseases, such as tuberculosis. Repurposing of anti-cancer drugs, such as everolimus, may be an effective way to supplement the standard antibiotic treatment. Individuals with type 2 diabetes are increasingly susceptible to co-morbidities and co-infections including

Indexed as

ImmunityAdolescentAdultAgedDiabetes Mellitus, Type 2EverolimusFemaleGranulomaHumansImmunosuppressive AgentsLeukocytes, MononuclearMacrophagesMaleMiddle AgedMycobacterium tuberculosisTuberculosisEverolimusImmunosuppressive AgentsEverolimusfoamy macrophagesMycobacterium tuberculosis

Identifiers

PMID34062056
PMCPMC8993225

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.